Guidelines for Pathogen Detection Using qPCR in Aquatic Systems

Pulling together a general framework for designing, validating, and applying real-time quantitative PCR to detect and quantify parasites and pathogens in aquatic hosts and environmental samples. It generalizes the assay-development workflow we used for two marine bivalve pathogens — Perkinsus marinus (Dermo) in the eastern oyster (De Faveri et al. 2009) and Quahog Parasite Unknown (QPX) in the hard clam (Lyons et al. 2006) — and lines it up with the MIQE reporting standards (Bustin et al. 2009). Meant as a checklist and reference, not a fixed protocol; specific reagents, cyclers, and thresholds get tuned per system.

1. Decide whether qPCR is the right tool

qPCR is worth developing when you need one or more of: higher sensitivity than the standard reference method, species-level specificity (especially where congeners co-occur), quantitative output (cells or genome copies per unit tissue/volume), or higher throughput. For aquatic pathogens this often matters because traditional culture-based diagnostics (e.g., Ray’s fluid thioglycollate medium for Perkinsus) cannot discriminate between morphologically similar species and miss low-intensity infections. qPCR is not a free replacement: it requires up-front design, validation, and ongoing controls, and it detects DNA, not viability. Plan to run it alongside, not instead of, the reference method during development.

2. Target selection

Choose a genomic region that is conserved enough to be reliably present across all life stages and strains of the target, but variable enough to separate it from close relatives.

Ribosomal DNA / ITS regions are the common default for protistan and fungal-like aquatic pathogens. Both reference assays targeted rDNA — the ITS region between the 5.8S and 28S genes for P. marinus, and rDNA-associated sequence for QPX. Multicopy rDNA boosts sensitivity, but copy number can vary, so calibrate quantification to cells rather than assuming a fixed copies-per-organism.
Confirm presence across life stages. A frequent pitfall is assuming the target sequence is equally abundant in all stages (trophont, meront, hypnospore, resting/cyst forms). Verify detection in the stages relevant to your sampling.
Check against public databases and, critically, against the genomes of co-occurring and sister taxa before committing. Design with maximum dissimilarity to the nearest relatives (the P. marinus assay was explicitly constrained against P. olseni).

3. Primer and probe design

Use a hydrolysis (dual-labeled) probe rather than intercalating dye when specificity is paramount; the probe adds a third sequence-specific check beyond the two primers. A 5′ reporter / 3′ quencher (e.g., FAM/BHQ) configuration is standard.
Design with software that enforces amplicon length, Tm matching, and minimal secondary structure (e.g., Primer Express or equivalent), then add an explicit specificity constraint against the closest relative’s sequence.
Keep amplicons short (typically ~70–150 bp) for efficient amplification from degraded or environmental DNA.
Order primers/probe from a single reputable synthesis source and record lot numbers.

4. Sample collection, preservation, and tissue selection

Sample the tissue or matrix where the pathogen concentrates. For Perkinsus and QPX this meant mantle/rectum and inflammatory nodules; for environmental work it meant water-column aggregates (marine snow), pseudofeces, and sediment.
Use sterile dissection and process paired tissue sets when validating against a reference method — one set per method, from the same individual — so the comparison is genuinely matched.
Standardize tissue mass (e.g., 30 mg wet weight) so results normalize cleanly to cells or copies per gram.
Preserve to protect DNA: freeze (−20 °C or colder) or use an appropriate fixative/preservative; avoid iodine staining on material destined for PCR, as iodine can bind DNA and suppress amplification.

5. DNA extraction: balance throughput against purity

Column/kit extractions (e.g., silica-membrane kits) yield clean, stable DNA but are slow, multi-step, and raise cross-contamination risk through repeated transfers — limiting batch size for surveillance-scale work.
Chelex resin extraction is a fast, single-tube alternative that the reference studies showed gives amplification comparable to kits for these targets. It trades long-term DNA stability for speed; Chelex extracts should be stored at 4 °C and used relatively promptly, whereas kit DNA stores frozen.
Validate any chosen method against a reference extraction using both neat dilution series and host tissue, confirming no significant difference in Cq before adopting it for routine use.
Include a reagent-only extraction blank for every extraction batch, carried through the entire protocol, to catch reagent or workflow contamination.

6. Standard curves and quantification

Calibrate to counted cells, not just DNA mass. Quantify cultured organisms (replicate hemocytometer counts) before extraction, then build the standard curve from serial dilutions of those counted cells. This lets Cq values be translated directly into organism abundance — the step that makes the assay quantitative and comparable across studies.
Span at least five orders of magnitude in the dilution series (the reference assays ran ~600 to 6,000,000 cells per gram / per reaction equivalent).
Require a strong linear fit (R² ≥ 0.98–0.99) and report slope and amplification efficiency.
Run all standards, samples, and controls in duplicate (technical replicates), at minimum.
Re-run or verify the standard curve periodically rather than relying indefinitely on one historical curve; report consistency across runs.

7. Controls (run every plate)

No-template control (NTC): reagents, no DNA — detects reagent/primer contamination.
Extraction blanks: as above, one per extraction batch.
Positive control / standard dilutions: confirm the assay is performing and anchor quantification.
Negative biological controls: tissue from a site or stock with a long verified history of being pathogen-free, to establish the host-matrix baseline.

8. Sensitivity and limit of detection

Determine the lowest reliably detectable quantity using the serial dilution series, both with and without host/environmental matrix. The P. marinus assay detected as few as ~3 cells; QPX resolved down to ~1 organism per reaction.
Report the limit of detection explicitly and note how it compares to the reference method — qPCR commonly detects an order of magnitude or more below culture-based assays, which materially reduces false negatives at low infection intensity.

9. Specificity validation

Test the assay against the most closely related species (phylogenetic neighbors) and the species most likely to co-occur in the same host or water body. The P. marinus assay was screened against P. olseni (nearest relative) and P. chesapeaki (geographic co-occurrence); the QPX assay was screened against ~29 thraustochytrid-like isolates from multiple regions.
Require no amplification of non-target DNA across a relevant concentration range, not just at a single dilution.

10. Inhibition and matrix effects

PCR inhibitors (humic acids, polysaccharides, host compounds) are a recognized cause of false negatives in environmental and tissue samples.
Test for inhibition by comparing standard curves built from neat cells versus cells spiked into host tissue or environmental matrix. If the curves do not differ significantly, the matrix is not inhibiting and the laborious “spiking” step can be dropped from routine runs — a genuine time savings demonstrated in both reference studies.
Where matrix effects do appear, consider dilution of template, an internal amplification control, or additional cleanup.

11. Life-stage and target-presence considerations

Confirm the assay detects DNA from all relevant life stages present in your samples. For Perkinsus, paired incubated (hypnospore) versus non-incubated (trophont) tissues showed only marginal differences, with iodine binding and uneven within-host parasite distribution as plausible sources of the small discrepancy.
Remember qPCR quantifies DNA, which does not distinguish viable from non-viable organisms. Interpret abundance accordingly, and pair with viability-sensitive methods if live-organism counts are the question.

12. Validation against the reference method

Process matched tissue from the same individuals with both qPCR and the established reference assay across a full range of infection intensities.
Use regression to relate qPCR output to the reference scale. The P. marinus work plotted Cq and cell density against the Mackin index (R² ~0.94–0.98), allowing molecular results to be expressed on the familiar diagnostic scale — a model worth replicating, because it lets a new assay integrate with historical datasets rather than orphaning them.
Quantitative output also enables refinement of legacy ordinal scales into finer, cell-count-anchored categories.

13. Environmental and surveillance application

Demonstrate the assay on naturally contaminated field samples, not just spiked controls — water aggregates, feces/pseudofeces, sediment, and lesion tissue as appropriate.
For surveillance, throughput and contamination control dominate: favor single-tube extraction, strict plate controls, and batch blanks.
A quantitative, sequence-specific assay supports a universal, lab-transferable intensity scale, addressing the cross-laboratory inconsistency that plagues subjective, scale-dependent visual diagnostics.

14. Data analysis and reporting (MIQE-aligned)

Report enough that another lab can reproduce and benchmark the assay:

Target gene/region, accession(s), amplicon length, and primer/probe sequences with modifications.
Extraction method, input mass/volume, and elution details.
Reaction chemistry, volumes, primer/probe concentrations, and cycling conditions.
Standard curve: dilution range, slope, R², amplification efficiency, and how it maps to cells or copies.
Limit of detection, specificity panel and results, replicate structure, and all control results.
Cq values (and the threshold/baseline method used), with any reference-method correlation statistics.

15. Quality assurance and interlaboratory standardization

Calibrate against accepted standards and, where feasible, validate across more than one laboratory to remove individual-interpretation bias — a step long recommended (e.g., OIE proficiency standards) but rarely practiced for these pathogens.
Maintain reagent lot records, periodic positive-control checks, and a documented threshold-setting convention so results remain comparable over time.

Key references

De Faveri, J., Smolowitz, R. M., & Roberts, S. B. (2009). Development and validation of a real-time quantitative PCR assay for the detection and quantification of Perkinsus marinus in the eastern oyster, Crassostrea virginica. Journal of Shellfish Research, 28(3), 459–464.
Lyons, M. M., Smolowitz, R., Dungan, C. F., & Roberts, S. B. (2006). Development of a real-time quantitative PCR assay for the hard clam pathogen Quahog Parasite Unknown (QPX). Diseases of Aquatic Organisms, 72(1), 45–52.
Bustin, S. A., et al. (2009). The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clinical Chemistry, 55(4), 611–622.

--- title: "Guidelines for Pathogen Detection Using qPCR in Aquatic Systems" description: "A practical framework generalized from the Dermo and QPX assay-development work, aligned to MIQE" categories: [Aquaculture, Reading Notes] #choose "Aquaculture", "Computing", "Epigenetics", "Genomics", "Lab Updates", "Reading Notes", "Transcriptomics" #citation: date: 06-10-2026 image: "images/clipboard-1329639524.png" # finding a good image author: - name: Steven Roberts url: orcid: 0000-0001-8302-1138 affiliation: Professor, UW - School of Aquatic and Fishery Sciences affiliation-url: https://robertslab.info #url: # self-defined draft: false # setting this to `true` will prevent your post from appearing on your listing page until you're ready! format: html: toc: true # ← enable TOC toc-location: left # or: right, body toc-depth: 3 # how many heading levels to show code-fold: FALSE code-tools: true code-copy: true highlight-style: github code-overflow: wrap #runtime: shiny --- <a href="https://robertslab.github.io/resources/Agentic-Coding-Tools/#five-level-rubric"><img src="https://img.shields.io/badge/AI%20Use-Level%204%20Substantial%20AI%20Contribution-red" alt="AI Use Level 4: Substantial AI contribution"/></a> Pulling together a general framework for designing, validating, and applying real-time quantitative PCR to detect and quantify parasites and pathogens in aquatic hosts and environmental samples. It generalizes the assay-development workflow we used for two marine bivalve pathogens — *Perkinsus marinus* (Dermo) in the eastern oyster (De Faveri et al. 2009) and Quahog Parasite Unknown (QPX) in the hard clam (Lyons et al. 2006) — and lines it up with the MIQE reporting standards (Bustin et al. 2009). Meant as a checklist and reference, not a fixed protocol; specific reagents, cyclers, and thresholds get tuned per system. ## 1. Decide whether qPCR is the right tool qPCR is worth developing when you need one or more of: higher sensitivity than the standard reference method, species-level specificity (especially where congeners co-occur), quantitative output (cells or genome copies per unit tissue/volume), or higher throughput. For aquatic pathogens this often matters because traditional culture-based diagnostics (e.g., Ray's fluid thioglycollate medium for *Perkinsus*) cannot discriminate between morphologically similar species and miss low-intensity infections. qPCR is not a free replacement: it requires up-front design, validation, and ongoing controls, and it detects DNA, not viability. Plan to run it alongside, not instead of, the reference method during development. ## 2. Target selection Choose a genomic region that is conserved enough to be reliably present across all life stages and strains of the target, but variable enough to separate it from close relatives. - **Ribosomal DNA / ITS regions** are the common default for protistan and fungal-like aquatic pathogens. Both reference assays targeted rDNA — the ITS region between the 5.8S and 28S genes for *P. marinus*, and rDNA-associated sequence for QPX. Multicopy rDNA boosts sensitivity, but copy number can vary, so calibrate quantification to cells rather than assuming a fixed copies-per-organism. - **Confirm presence across life stages.** A frequent pitfall is assuming the target sequence is equally abundant in all stages (trophont, meront, hypnospore, resting/cyst forms). Verify detection in the stages relevant to your sampling. - **Check against public databases and, critically, against the genomes of co-occurring and sister taxa** before committing. Design with maximum dissimilarity to the nearest relatives (the *P. marinus* assay was explicitly constrained against *P. olseni*). ## 3. Primer and probe design - Use a **hydrolysis (dual-labeled) probe** rather than intercalating dye when specificity is paramount; the probe adds a third sequence-specific check beyond the two primers. A 5′ reporter / 3′ quencher (e.g., FAM/BHQ) configuration is standard. - Design with software that enforces amplicon length, Tm matching, and minimal secondary structure (e.g., Primer Express or equivalent), then add an explicit specificity constraint against the closest relative's sequence. - Keep amplicons short (typically \~70–150 bp) for efficient amplification from degraded or environmental DNA. - Order primers/probe from a single reputable synthesis source and record lot numbers. ## 4. Sample collection, preservation, and tissue selection - **Sample the tissue or matrix where the pathogen concentrates.** For *Perkinsus* and QPX this meant mantle/rectum and inflammatory nodules; for environmental work it meant water-column aggregates (marine snow), pseudofeces, and sediment. - Use **sterile dissection** and process paired tissue sets when validating against a reference method — one set per method, from the same individual — so the comparison is genuinely matched. - Standardize tissue mass (e.g., 30 mg wet weight) so results normalize cleanly to cells or copies per gram. - Preserve to protect DNA: freeze (−20 °C or colder) or use an appropriate fixative/preservative; avoid iodine staining on material destined for PCR, as iodine can bind DNA and suppress amplification. ## 5. DNA extraction: balance throughput against purity - **Column/kit extractions** (e.g., silica-membrane kits) yield clean, stable DNA but are slow, multi-step, and raise cross-contamination risk through repeated transfers — limiting batch size for surveillance-scale work. - **Chelex resin extraction** is a fast, single-tube alternative that the reference studies showed gives amplification comparable to kits for these targets. It trades long-term DNA stability for speed; Chelex extracts should be stored at 4 °C and used relatively promptly, whereas kit DNA stores frozen. - **Validate any chosen method against a reference extraction** using both neat dilution series and host tissue, confirming no significant difference in Cq before adopting it for routine use. - Include a **reagent-only extraction blank for every extraction batch**, carried through the entire protocol, to catch reagent or workflow contamination. ## 6. Standard curves and quantification - **Calibrate to counted cells, not just DNA mass.** Quantify cultured organisms (replicate hemocytometer counts) *before* extraction, then build the standard curve from serial dilutions of those counted cells. This lets Cq values be translated directly into organism abundance — the step that makes the assay quantitative and comparable across studies. - Span at least **five orders of magnitude** in the dilution series (the reference assays ran \~600 to 6,000,000 cells per gram / per reaction equivalent). - Require a strong linear fit (R² ≥ 0.98–0.99) and report slope and amplification efficiency. - Run **all standards, samples, and controls in duplicate** (technical replicates), at minimum. - Re-run or verify the standard curve periodically rather than relying indefinitely on one historical curve; report consistency across runs. ## 7. Controls (run every plate) - **No-template control (NTC):** reagents, no DNA — detects reagent/primer contamination. - **Extraction blanks:** as above, one per extraction batch. - **Positive control / standard dilutions:** confirm the assay is performing and anchor quantification. - **Negative biological controls:** tissue from a site or stock with a long verified history of being pathogen-free, to establish the host-matrix baseline. ## 8. Sensitivity and limit of detection - Determine the lowest reliably detectable quantity using the serial dilution series, both **with and without host/environmental matrix**. The *P. marinus* assay detected as few as \~3 cells; QPX resolved down to \~1 organism per reaction. - Report the limit of detection explicitly and note how it compares to the reference method — qPCR commonly detects an order of magnitude or more below culture-based assays, which materially reduces false negatives at low infection intensity. ## 9. Specificity validation - Test the assay against **the most closely related species** (phylogenetic neighbors) and **the species most likely to co-occur** in the same host or water body. The *P. marinus* assay was screened against *P. olseni* (nearest relative) and *P. chesapeaki* (geographic co-occurrence); the QPX assay was screened against \~29 thraustochytrid-like isolates from multiple regions. - Require **no amplification** of non-target DNA across a relevant concentration range, not just at a single dilution. ## 10. Inhibition and matrix effects - PCR inhibitors (humic acids, polysaccharides, host compounds) are a recognized cause of false negatives in environmental and tissue samples. - Test for inhibition by comparing standard curves built from **neat cells** versus **cells spiked into host tissue or environmental matrix**. If the curves do not differ significantly, the matrix is not inhibiting and the laborious "spiking" step can be dropped from routine runs — a genuine time savings demonstrated in both reference studies. - Where matrix effects do appear, consider dilution of template, an internal amplification control, or additional cleanup. ## 11. Life-stage and target-presence considerations - Confirm the assay detects DNA from **all relevant life stages** present in your samples. For *Perkinsus*, paired incubated (hypnospore) versus non-incubated (trophont) tissues showed only marginal differences, with iodine binding and uneven within-host parasite distribution as plausible sources of the small discrepancy. - Remember qPCR quantifies DNA, which **does not distinguish viable from non-viable organisms**. Interpret abundance accordingly, and pair with viability-sensitive methods if live-organism counts are the question. ## 12. Validation against the reference method - Process **matched tissue from the same individuals** with both qPCR and the established reference assay across a full range of infection intensities. - Use regression to relate qPCR output to the reference scale. The *P. marinus* work plotted Cq and cell density against the Mackin index (R² \~0.94–0.98), allowing molecular results to be expressed on the familiar diagnostic scale — a model worth replicating, because it lets a new assay integrate with historical datasets rather than orphaning them. - Quantitative output also enables **refinement of legacy ordinal scales** into finer, cell-count-anchored categories. ## 13. Environmental and surveillance application - Demonstrate the assay on **naturally contaminated field samples**, not just spiked controls — water aggregates, feces/pseudofeces, sediment, and lesion tissue as appropriate. - For surveillance, throughput and contamination control dominate: favor single-tube extraction, strict plate controls, and batch blanks. - A quantitative, sequence-specific assay supports **a universal, lab-transferable intensity scale**, addressing the cross-laboratory inconsistency that plagues subjective, scale-dependent visual diagnostics. ## 14. Data analysis and reporting (MIQE-aligned) Report enough that another lab can reproduce and benchmark the assay: - Target gene/region, accession(s), amplicon length, and primer/probe sequences with modifications. - Extraction method, input mass/volume, and elution details. - Reaction chemistry, volumes, primer/probe concentrations, and cycling conditions. - Standard curve: dilution range, slope, R², amplification efficiency, and how it maps to cells or copies. - Limit of detection, specificity panel and results, replicate structure, and all control results. - Cq values (and the threshold/baseline method used), with any reference-method correlation statistics. ## 15. Quality assurance and interlaboratory standardization - Calibrate against **accepted standards** and, where feasible, validate across **more than one laboratory** to remove individual-interpretation bias — a step long recommended (e.g., OIE proficiency standards) but rarely practiced for these pathogens. - Maintain reagent lot records, periodic positive-control checks, and a documented threshold-setting convention so results remain comparable over time. ## Quick-reference checklist - [ ] qPCR justified over (or alongside) the reference method - [ ] Target region present in all life stages; dissimilar to relatives - [ ] Dual-labeled probe designed with explicit specificity constraint - [ ] Pathogen-concentrating tissue/matrix sampled; mass standardized - [ ] Extraction method validated against a reference; batch blanks included - [ ] Standard curve calibrated to counted cells, ≥5 orders of magnitude, R² ≥ 0.98 - [ ] NTC, extraction blanks, positive and negative biological controls on every plate - [ ] Limit of detection determined with and without matrix - [ ] Specificity confirmed against nearest relatives and co-occurring species - [ ] Inhibition tested (neat vs. spiked); spiking dropped only if no difference - [ ] Validated against reference method on matched tissue across intensity range - [ ] Demonstrated on natural field samples - [ ] MIQE-aligned reporting; interlaboratory calibration where possible ## Key references - De Faveri, J., Smolowitz, R. M., & Roberts, S. B. (2009). Development and validation of a real-time quantitative PCR assay for the detection and quantification of *Perkinsus marinus* in the eastern oyster, *Crassostrea virginica*. *Journal of Shellfish Research*, 28(3), 459–464. - Lyons, M. M., Smolowitz, R., Dungan, C. F., & Roberts, S. B. (2006). Development of a real-time quantitative PCR assay for the hard clam pathogen Quahog Parasite Unknown (QPX). *Diseases of Aquatic Organisms*, 72(1), 45–52. - Bustin, S. A., et al. (2009). The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. *Clinical Chemistry*, 55(4), 611–622.